19 May 2013
Keywords: sensus, files, acromegaly, drug, usa, development, filed
Article | 08 February 2001
Sensus Drug Development has filed a New Drug Application in the USAfor Somavert (pegvisomant), a growth hormone receptor antagonist for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 February 2001
9 February 2001
17 May 2013
© 2013 thepharmaletter.com